63 completed, 13 unknown, 6 recruiting, 4 active not recruiting. 36 Phase 4, 21 Phase 3, 20 Phase 1, 10 Not applicable, 3 Phase 2.
Follow pitavastatin: new trials by email Literature Review of pitavastatin trials Research Report on pitavastatin
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase 1 Clinical Trial to Evaluate the Safety and the Pharmacokinetic Drug-Drug Interaction Between HUC2A-752-A and HUC2A-752-B in Healthy Adults Losartan (COZZAR®), Pitavastatin plus Ezetemibe - Hypertension | Phase 1 | Not yet recruiting | Huons Co., Ltd. | 30 | 2026-10-01 | 2026-09-10 |
| Comparing Inclisiran Versus Statin for Primary Aldosteronism inclisiran, Lipophilic statins (such as Simvastatin, Atorvastatin, Fluvastatin, Lovastatin,Pitavastatin), Spironolactone (drug) - Primary Aldosteronism | Not applicable | Recruiting | Third Military Medical University | 50 | 2026-10-01 | 2026-10-21 |
| Study of ECC4703 With Sulfasalazine and Pitavastatin ECC4703, Sulfasalazine, Pitavastatin - Non-alcoholic Fatty Liver Disease (NAFLD), Dyslipidaemia | Phase 1 | Recruiting | Eccogene | 40 | 2026-08-07 | 2026-09-10 |
| Livalozet Versus High-intensity Statin in Older Patients With Coronary Artery Disease Undergoing Percutaneous Coronary Intervention Pitavastatin/ezetimibe, Atorvastatin or Rosuvastatin - Acute Coronary Syndrome (ACS) Undergoing Percutaneous Coronary Intervention (PCI) | Not applicable | Not yet recruiting | Samsung Medical Center | 5000 | 2026-06-01 | 2026-06-10 |
| A Phase 1 Study to Assess the Effect of ABBV-722 on Midazolam, Digoxin, Pitavastatin, Metformin, and Sitagliptin Drug Levels in Healthy Adults. ABBV-722, Midazolam, Metformin - Healthy Volunteers | Phase 1 | Completed | AbbVie | 12 | 2026-04-30 | 2026-08-20 |
| PhIbRandomGemcitabine(G)w/or w/Out Pitavastatin(P)MainTx UnresecPancreaticAdenocarcinoma(uPDAC) Pitavastatin - Pancreatic Cancer, Pancreatic Cancer Metastatic | Phase 1 | Recruiting | University of California, Irvine | 18 | 2026-03-24 | 2026-05-04 |
| TRIal of STatin Therapy Effect on Androgen Status and Erectile functioN in Men Pitavastatin 1-4 mg daily, Rosuvastatin 20-40 mg daily - Erectile Dysfunction Due to Arterial Disease, Atheroscleroses | Phase 2 | Recruiting | Lomonosov Moscow State University Medical Research and Educational Center | 150 | 2026-03-05 | 2026-03-16 |
| Chemotherapy Plus Pitavastatin Guided by Patient-Derived Tumor-like Cell Clusters in Refractory Non-Small Cell Lung Cancer Pitavastatin 1 mg daily or 4 mg daily - Non-Small Cell Lung Cancer | Phase 1 | Not yet recruiting | Chang Chen | 22 | 2026-01-10 | 2026-01-20 |
| GUIDE-CAC: Statin-Ezetimibe Without Aspirin vs. Statin Monotherapy With Aspirin in High Coronary Calcification Pitavastatin 4mg and ezetimibe 10mg, taken once daily, Pitavastatin 2 mg with aspirin 100 mg, taken once daily. - Primary Prevention, Vascular Calcification | Phase 4 | Recruiting | Asan Medical Center | 7435 | 2025-07-09 | 2025-08-07 |
| A Study Investigating the Safety of RO7795081 and the Effect of RO7795081 on How the Body Processes Pitavastatin and Rosuvastatin in Otherwise Healthy Overweight or Obese Adult Participants RO7795081, Placebo, Rosuvastatin - Overweight, Obesity | Phase 1 | Active not recruiting | Hoffmann-La Roche | 40 | 2025-06-04 | 2026-09-09 |
| A Research Study of the Effect of Etavopivat on Other Drugs in Healthy Participants Etavopivat, Digoxin, Pitavastatin - Healthy Volunteers Sickle Cell Disease, Thalassemia | Phase 1 | Completed | Novo Nordisk A/S | 37 | 2025-02-06 | 2026-09-29 |
| A Study to Assess the Effect of Ceftobiprole on the PK of Pitavastatin and on Plasma Levels of Coproporphyrin pitavastatin, pitavastatin single dose combined with ceftobiprole - Drug-drug Interaction Study | Phase 1 | Completed | Basilea Pharmaceutica | 12 | 2025-01-17 | 2026-04-21 |
| Optimising Metabolic Management for People With Human Immunodeficiency Virus (HIV) on Integrase Based Antiretroviral Therapy (ART) Dapagliflozin 10mg Tab, Pitavastatin 4 Mg Oral Tablet, Rosuvastatin and Ezetimibe - HIV Infections, Weight Gain | Phase 3 | Active not recruiting | Kirby Institute | 300 | 2024-12-16 | 2026-07-22 |
| Repurposed Drugs in Research for Cancer Clinical Trials- Pitavastatin Pitavastatin calcium - Glioblastoma Multiforme, Adult, Recurrent Glioblastoma | Early Phase 1 | Completed | C.Dirven | 12 | 2024-01-18 | 2024-08-07 |
| Long-term Comparison of Pitavastatin/Ezetimibe and Pitavastatin in Patients With Hypercholesterolemia and Elevated Triglycerides Pitavastatin 4mg, Ezetimibe 10 mg, Placebo (for Pitavastatin/Ezetimibe) - Hypercholesterolemia | Phase 4 | Active not recruiting | JW Pharmaceutical | 88 | 2023-08-21 | 2026-03-02 |
| Effects of Pitavastatin or Combination of Pitavastatin and Ezetimibe on Glucose Metabolism Compared to AtoRvastatin in atheroscLerotic Cardiovascular Disease Patients With Metabolic Syndrome: The EZ-PEARL Randomized Trial Pitavastatin, Pitavastatin plus Ezetemibe, Atorvastatin - Dyslipidemias, Atherosclerotic Cardiovascular Disease | Not applicable | Recruiting | Yonsei University | 250 | 2023-06-13 | 2026-07-07 |
| Evaluation of the Pharmacokinetics of Microdose Midazolam, Dabigatran, Pitavastatin, Atorvastatin and Rosuvastatin in Diabetic Patients The combinations of 10 µg midazolam, 375 µg dabigatran etexilate, 10 µg pitavastatin, 50 µg rosuvastatin, and 100 µg atorvastatin were administered to diabetic patients on an empty stomach. - Diabetes | Phase 4 | Unknown | Peking University Third Hospital | 48 | 2023-03-05 | 2024-02-22 |
| A Clinical Study to Evaluate the Pharmacokinetics of Microdose Midazolam, Dabigatran, Pitavastatin, Atorvastatin and Rosuvastatin in Healthy Volunteers and Renal Impairment Patients Midazolam, dabigatran etexilate, pitavastatin, rosuvastatin and atorvastatin - Chronic Kidney Disease | Phase 4 | Unknown | Peking University Third Hospital | 60 | 2022-07-15 | 2023-02-28 |
| Real World Evidence Study of Statin Use in Brazil Statin - Cardiovascular Diseases, Myocardial Infarction | Completed | Hospital Israelita Albert Einstein | 2133900 | 2021-11-19 | 2024-05-14 | |
| Efficacy and Safety of Pitavastatin and PCSK9 Inhibitors in Liver Transplant Patients Pitavastatin, PCSK9 inhibitor - Dyslipidemias, Hyperlipidemias | Phase 4 | Active not recruiting | National Medical Research Center for Therapy and Preventive Medicine | 59 | 2021-10-01 | 2025-01-22 |
Showing 20 of 93. Sign in to see all of them.
Dyslipidemias (21) · Hypercholesterolemia (21) · Hyperlipidemias (9) · Hypertension (9) · Cardiovascular Diseases (8) · Coronary Artery Disease (4) · Metabolic Syndrome (4) · Atherosclerosis (3) · Coronary Disease (3) · Obesity (3) · Acute Coronary Syndrome (2) · Angina, Stable (2) · Diabetes Mellitus (2) · Diabetes Mellitus, Type 2 (2) · Inflammation (2)
JW Pharmaceutical (13) · Kowa Research Europe (10) · Kowa Research Institute, Inc. (8) · Asan Medical Center (3) · Hanlim Pharm. Co., Ltd. (2) · Hoffmann-La Roche (2) · Orient Pharma Co., Ltd. (2) · Peking University Third Hospital (2) · University of California, Irvine (2) · Yonsei University (2) · AbbVie (1) · Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections (1) · Aichi Gakuin University (1) · Alios Biopharma Inc. (1) · Basilea Pharmaceutica (1)
South Korea (22) · United States (21) · Netherlands (12) · Japan (10) · Denmark (9) · United Kingdom (9) · China (7) · Germany (7) · India (6) · Poland (5) · Russia (5) · Spain (5) · Israel (4) · Italy (4) · Sweden (4)
Dragos Budinski, Med Dr. (5) · Dragos Budinski, MD (4) · Roger Morgan, MD, FACS (3) · Kyun Seop Bae, MD (2) · Masunori Matsuzaki, MD, PhD (2) · Adeep Puri (1) · Alexandra Ershova, PhD (1) · Asita Wongprikorn (1) · Byeong-Keuk Kim (1) · Chang Beom Lee (1) · Chen-Huan Chen (1) · Chiau-Suong Liau (1)
PMID 24328357, PMID 32645163, PMID 37368931, PMID 38180893, PMID 39159048, PMID 19539181, PMID 19608026, PMID 19785568, PMID 20080236, PMID 20467151, PMID 20684825, PMID 21874537, PMID 21874538, PMID 22410289, PMID 22627182, PMID 22679249, PMID 22689416, PMID 22884685, PMID 22901557, PMID 22972364, PMID 23289728, PMID 23324995, PMID 24098467, PMID 24531309, PMID 24825411, PMID 24835329, PMID 24998014, PMID 25027585, PMID 25202920, PMID 25378974, PMID 26486974, PMID 26922296, PMID 27304841, PMID 27581680, PMID 28121706, PMID 28252528, PMID 28277924, PMID 28416195, PMID 29078817, PMID 29212965, PMID 29574070, PMID 29735587, PMID 30047013, PMID 30187345, PMID 30239757, PMID 30928823, PMID 30928825, PMID 31247117, PMID 31752850, PMID 32037254
2005 (1), 2015 (1), 2023 (1), R01AG054366 (1), U01HL123336 (1), U01HL123339 (1), UM1AI068636 (1)